NasdaqGS:ABSIBiotechs
How New AI Partnerships and $64 Million Raise at Absci (ABSI) Have Changed Its Investment Story
Earlier this month, Absci Corporation announced a collaboration with Oracle Cloud Infrastructure and AMD to advance its AI-driven drug discovery platform, and detailed expanded partnerships and scientific advisory board appointments supporting its dermatology initiatives.
With a fresh US$64 million capital raise and advanced AI infrastructure, Absci is reinforcing both its financial stability and technological capabilities in the biotech sector.
Next, we’ll examine how Absci’s emphasis on AI...